Tuberculosis-Associated Anemia: A Narrative Review | Article
Our Picks For At-Home Bacterial Vaginosis Test 2023
Final VerdictOverall, the most comprehensive at-home test provider is LetsGetChecked. The brand offers two health test options that check for BV. It works with CLIA-certified and CAP-accredited labs to provide results within two to five days and even offers telehealth consultation and prescription treatment should you need it. In addition to BV testing, LetsGetChecked has other convenient at-home testing kits to help you keep tabs on your overall health.
There are a few solid choices for at-home BV tests. Some budget tests, like ones from AZO or Walgreens, work in a pinch and might help you differentiate between a yeast infection and something like BV, which requires medical treatment. Other tests, like those from Evvy and myLAB Box stand out for features like memberships and speedy results.
Compare the Best At-Home Bacterial Vaginosis Tests Guide to Choosing an At-Home Bacterial Vaginosis Test What Can At-Home Bacterial Vaginosis Tests Tell You?This depends on the type of test. A simple pH test can only tell you whether your vaginal pH is off. Abnormal pH might indicate an infection like bacterial vaginosis, but it can't diagnose BV since other conditions can cause your pH to be out-of-whack. That said, says nurse and medical writer Lindsay Modglin explains that regular testing can help you monitor pH and serve as an early warning sign of an imbalance.
A more accurate way to diagnose BV, says Modglin is to lab test for the presence of BV-causing bacteria in a vaginal swab. "Vaginal swab tests are the most common and accurate way to diagnose BV," she says. Urine tests not doctor-recommended to accurately detect BV. The American College of Obstetricians and Gynecologists only recommends vaginal swabs.
Who Should Not Use an At-Home Bacterial Vaginosis Test?"People who are pregnant, have a known STI, or are experiencing unusual vaginal bleeding should not use at-home BV tests," says Modglin. In this case, it's a good idea to make a medical appointment and see a doctor in person.
How to Compare At-Home Bacterial Vaginosis TestsThere are various factors to consider when deciding which at-home bacterial vaginosis test is best for you. These factors include:
BV is a condition that results from a bacterial imbalance in the vagina. Anything that disrupts your vagina's pH balance can cause BV, like sex or douching. Many people don't have symptoms, but abnormal vaginal discharge and odors, and vaginal irritation can occur.
You can expect a test from a reputable company that uses accredited labs to be fairly accurate. However, human error can contribute to inaccurate results, so important to follow instructions for sample collection.
A company may connect you with a medical professional if you receive a positive result from an at-home BV test. If not, it's a good idea to see someone in person for treatment recommendations. Additionally, Modglin says that pregnant people or those experiencing unusual symptoms should see a doctor in person.
In some cases, BV will resolve on its own, says Modglin. However, she adds that it's best to seek treatment to avoid recurring infections and complications down the line.
While BV may go away on its own, Modglin explains that doctors typically treat this type of infection with antibiotics, which are not available OTC.
We looked at several at-home testing companies to find ones that provide BV testing. While many companies offer STI testing, not all offer testing for bacteria that causes BV. We also looked at five different drugstore-based pH tests.
Our first consideration was to find at-home test options that are accurate (CLIA, CAP, CLEP-certified labs), easy to use, and reliable, with reasonable shipping and lab processing times. Another key factor was whether consultations with medical personnel are available. And while pricing wasn't a main deciding factor, we highlighted testing options at various price points to suit different budgets.
Bacterial Vaginosis Drug Market Share And Forecast Till 2030
The MarketWatch News Department was not involved in the creation of this content.
Mar 29, 2023 (The Expresswire) -- The "Bacterial Vaginosis Drug Market" Study Describes how the technology industry is evolving and how major and emerging players in the industry are responding to long term opportunities and short-term challenges they face. One major attraction about Bacterial Vaginosis Drug Industry is its growth rate. Many major technology players are [Bayer, Pfizer, Sanofi, Piramal, Abbott, Galderma, Mission, Alkem, Xiuzheng, Teva, Perrigo, West-Ward, HPGC, Yunnan Baiyao, Starpharma, Novel, Edenvridge] have been looking into Bacterial Vaginosis Drug as a way to increase their market share and reach towards consumers.
What is the Bacterial Vaginosis Drug market growth?
Bacterial Vaginosis Drug Market Size is projected to Reach Multimillion USD by 2028, In comparison to 2023, at unexpected CAGR during the forecast Period 2023-2028.
Browse Detailed TOC, Tables and Figures with Charts which is spread across 113 Pages that provides exclusive data, information, vital statistics, trends, and competitive landscape details in this niche sector.
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Bacterial Vaginosis Drug market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters, we elaborate at full length on the impact of the pandemic and the war on the Bacterial Vaginosis Drug Industry
Final Report will add the analysis of the impact of Russia-Ukraine War and COVID-19 on this Bacterial Vaginosis Drug Industry.
TO KNOW HOW COVID-19 PANDEMIC AND RUSSIA UKRAINE WAR WILL IMPACT THIS MARKET - REQUEST SAMPLE
This research report is the result of an extensive primary and secondary research effort into the Bacterial Vaginosis Drug market. It provides a thorough overview of the market's current and future objectives, along with a competitive analysis of the industry, broken down by application, type and regional trends. It also provides a dashboard overview of the past and present performance of leading companies. A variety of methodologies and analyses are used in the research to ensure accurate and comprehensive information about the Bacterial Vaginosis Drug Market.
Which are the driving factors of the Bacterial Vaginosis Drug market?
Growing demand for [Hospital, Pharmacy, Other] around the world has had a direct impact on the growth of the Bacterial Vaginosis Drug
The Bacterial Vaginosis Drug segments and sub-section of the market are illuminated below:
Based on Product Types the Market is categorized into [Rx, OTC] that held the largest Bacterial Vaginosis Drug market share In 2022.
Get a Sample PDF of report -https://www.360researchreports.Com/enquiry/request-sample/21060505
Bacterial Vaginosis Drug Market - Competitive and Segmentation Analysis:
2.How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Short Description About Bacterial Vaginosis Drug Market:
The Global Bacterial Vaginosis Drug market is anticipated to rise at a considerable rate during the forecast period, between 2022 and 2028. In 2021, the market is growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as l bacteriosis or Gardnerella vaginitis, a disease of the caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs.
Market Analysis and Insights: Global Bacterial Vaginosis Drug Market
The research report studies the Bacterial Vaginosis Drug market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
Due to the COVID-19 pandemic, the global Bacterial Vaginosis Drug market size is estimated to be worth USD 916.5 million in 2021 and is forecast to a readjusted size of USD 1130 million by 2028 with a CAGR of 3.0Percent during the forecast period 2022-2028.
Global Bacterial Vaginosis Drug key players include Bayer, Pfizer, Sanofi, Piramal, Abbott, etc. Global top five manufacturers hold a share about 20Percent. North America and Europe is the largest market, both with a share about 30Percent, followed by China, with a share about 10 percent. In terms of product, OTC is the largest segment, with a share about 70Percent. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.
Global Bacterial Vaginosis Drug Scope and Segment
The global Bacterial Vaginosis Drug market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Bacterial Vaginosis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.
Get a Sample Copy of the Bacterial Vaginosis Drug Report 2023
3.What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users. Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapters:
This Bacterial Vaginosis Drug Market Research/Analysis Report Contains Answers to your following Questions
Customization of the Report
Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Inquire more and share questions if any before the purchase on this report at -https://www.360researchreports.Com/enquiry/pre-order-enquiry/21060505
Detailed TOC of Global Bacterial Vaginosis Drug Market Insights and Forecast to 2028
Major Points from Table of Contents
Global Bacterial Vaginosis Drug Market Research Report 2023-2028, by Manufacturers, Regions, Types and Applications
1 Introduction1.1 Objective of the Study1.2 Definition of the Market1.3 Market Scope1.3.1 Market Segment by Type, Application and Marketing Channel1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East and Africa)1.4 Years Considered for the Study (2015-2028)1.5 Currency Considered (U.S. Dollar)1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics3.1 Driving Factors for this Market3.2 Factors Challenging the Market3.3 Opportunities of the Global Bacterial Vaginosis Drug Market (Regions, Growing/Emerging Downstream Market Analysis)3.4 Technological and Market Developments in the Bacterial Vaginosis Drug Market3.5 Industry News by Region3.6 Regulatory Scenario by Region/Country3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Bacterial Vaginosis Drug Market
4.1 Value Chain Status4.2 Upstream Raw Material Analysis4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)4.4 Distributors/Traders4.5 Downstream Major Customer Analysis (by Region)
5 Global Bacterial Vaginosis Drug Market-Segmentation by Type6 Global Bacterial Vaginosis Drug Market-Segmentation by Application
7 Global Bacterial Vaginosis Drug Market-Segmentation by Marketing Channel7.1 Traditional Marketing Channel (Offline)7.2 Online Channel
8 Competitive Intelligence Company Profiles
9 Global Bacterial Vaginosis Drug Market-Segmentation by Geography
9.1 North America9.2 Europe9.3 Asia-Pacific9.4 Latin America
9.5 Middle East and Africa
10 Future Forecast of the Global Bacterial Vaginosis Drug Market from 2023-2028
10.1 Future Forecast of the Global Bacterial Vaginosis Drug Market from 2023-2028 Segment by Region10.2 Global Bacterial Vaginosis Drug Production and Growth Rate Forecast by Type (2023-2028)10.3 Global Bacterial Vaginosis Drug Consumption and Growth Rate Forecast by Application (2023-2028)
11 Appendix11.1 Methodology12.2 Research Data Source
Continued….
Purchase this report (Price 3350 USD for a single-user license) -https://www.360researchreports.Com/purchase/21060505
About Us:
360 Research Reports is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Research Reports, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.
For More Related Reports Click Here :
How much is The Global Pinhole Detectors Market worth in the future?
How much is The Global Sinuscope Endoscopes Market worth in the future?
What are some factors restraining revenue growth of the global Dog Food and Snack market?
Who are the prominent manufacturers of Surfactants in Textile and Fibre Industry?
How much is the Growth Potential of the Nasal Kits Market?
What are some factors restraining revenue growth of the global Traction Battery market?
What are some factors restraining revenue growth of the global Implant Abutment market?
What are some factors restraining revenue growth of the global Direct-Access Genetic Testing market?
Size-of-the-global-Rear-Drive-Axle-Market
4WD Tractor Market with a magnificent growth in CAGR
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Bacterial Vaginosis Drug Market Share and Forecast till 2030
COMTEX_427824047/2598/2023-03-29T03:05:15
Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.Com. You can also contact MarketWatch Customer Service via our Customer Center.
The MarketWatch News Department was not involved in the creation of this content.
IU Researchers Make Discovery In Bacterial STIs
Researchers at the Indiana University School of Medicine have reportedly discovered that the bacteria that causes common vaginal infections can have a major presence in men and can be sexually transmitted.
"We looked at the urethral microbiome of healthy adult men and found that many of them actually had bacteria that is associated with bacterial vaginosis in women," said David Nelson, professor of microbiology and immunology at IU School of Medicine and co-corresponding author of the study. "These bacteria can be transmitted through heterosexual, vaginal sex, something that has never been shown in research before."
In a study published in the academic journal Cell Reports Medicine, the researchers looked at 110 distal urethral swab specimens from men with no urogenital symptoms, sexually transmitted infections or inflammation of the urethra.
"What we found was stunning," Nelson said. "These men had two types of colonized bacteria — one that was native to the penile urethra, and one that was from an outside source. This is the first time it has been shown that the human microbiome is primarily shaped by behavior."
Prediabetes Among American Children , Has More Than Doubled in the Last 20 Years. CNN reports the upward trend of prediabetes among the youth of America should be cause for concern. In the last 20 years, the rate of prediabetes in children in the United States has more than doubled, a new study says. Researchers found rates increased in nearly every subpopulation of young Americans. Regardless of education, income or ethnicity. Published in the journal 'JAMA Pediatrics,' the study followed children ages 12 to 19, . Observing data from the CDC's National Health and Nutrition Examination Survey from 1999 to 2018. In that period, the number of prediabetic children in America steadily rose from 11.6% to 28.2%. Prediabetes is a common condition in American adults, though experts say 80% who have it aren't aware they do. The condition results in higher- than-normal blood sugar levels. While not quite at diabetic levels, a prediabetic person is at a heightened risk of developing type 2 diabetes and heart disease. As a society we need to work together to reduce obesity and prediabetes in youth. , Dr. Robert Gabbay, chief science and medical officer at the American Diabetes Association, via CNN. This will take a broad public health approach from working in schools, families, and most importantly availability of healthy foods with a particular emphasis on populations that are (at) greatest risk... , Dr. Robert Gabbay, chief science and medical officer at the American Diabetes Association, via CNN
The researchers said that only men who reported having vaginal sex carried the bacteria. This, they said, is the first time anyone has discovered that bacterial vaginosis, which is a common bacterial infection among women, can be transmitted to men via sex. Scientists previously believed that urine was sterile and prevented this from being the case.
The researchers hope to study whether the infection can inversely be transmitted from men to women.
"Our research provides the first healthy baseline for clinicians and scientists to compare with diseased urogenital states," said Evelyn Toh, assistant research professor of microbiology and immunology and lead author of the paper. "Having established this baseline, we may be able to offer new insights into bacteria's role in urogenital diseases.
"There is still stigma in talking about sex, and hence STIs are often overlooked. However, STIs really impact women and minorities disproportionately, as well as socioeconomically disadvantaged people."
Comments
Post a Comment